IL145241A0 - Method of controlling weight gain associated with therapeutic drugs - Google Patents

Method of controlling weight gain associated with therapeutic drugs

Info

Publication number
IL145241A0
IL145241A0 IL14524100A IL14524100A IL145241A0 IL 145241 A0 IL145241 A0 IL 145241A0 IL 14524100 A IL14524100 A IL 14524100A IL 14524100 A IL14524100 A IL 14524100A IL 145241 A0 IL145241 A0 IL 145241A0
Authority
IL
Israel
Prior art keywords
weight gain
therapeutic drugs
gain associated
controlling weight
controlling
Prior art date
Application number
IL14524100A
Other languages
English (en)
Original Assignee
Knoll Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Knoll Gmbh filed Critical Knoll Gmbh
Publication of IL145241A0 publication Critical patent/IL145241A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL14524100A 1999-03-19 2000-03-17 Method of controlling weight gain associated with therapeutic drugs IL145241A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12534099P 1999-03-19 1999-03-19
PCT/US2000/007130 WO2000056313A1 (en) 1999-03-19 2000-03-17 Method of controlling weight gain associated with therapeutic drugs

Publications (1)

Publication Number Publication Date
IL145241A0 true IL145241A0 (en) 2002-06-30

Family

ID=22419292

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14524100A IL145241A0 (en) 1999-03-19 2000-03-17 Method of controlling weight gain associated with therapeutic drugs

Country Status (20)

Country Link
US (1) US6376552B1 (bg)
EP (1) EP1162965A1 (bg)
JP (1) JP2002539251A (bg)
KR (1) KR20020000784A (bg)
CN (1) CN1353603A (bg)
AU (1) AU3757800A (bg)
BG (1) BG105997A (bg)
BR (1) BR0009159A (bg)
CA (1) CA2367021A1 (bg)
CZ (1) CZ291864B6 (bg)
HU (1) HUP0200393A2 (bg)
IL (1) IL145241A0 (bg)
MX (1) MXPA01009467A (bg)
NO (1) NO20014480L (bg)
NZ (1) NZ514009A (bg)
PL (1) PL350919A1 (bg)
SK (1) SK13352001A3 (bg)
TR (1) TR200102695T2 (bg)
WO (1) WO2000056313A1 (bg)
ZA (1) ZA200107692B (bg)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002019998A2 (en) * 2000-09-08 2002-03-14 Eli Lilly And Company A method of treating weight gain associated with atypical antipsychotic use
BR0315084A (pt) * 2002-10-05 2005-08-16 Hanmi Pharm Ind Co Ltd Composição farmacêutica compreendendo hemiidrato cristalino de metanossulfonato de sibutramina
US20050131074A1 (en) * 2003-08-04 2005-06-16 Beckman Kristen M. Methods for treating metabolic syndrome
US20060035827A1 (en) * 2004-06-24 2006-02-16 Green Gary M Compositions and methods for the treatment or prevention of gallbladder disease
KR20060080818A (ko) 2005-01-06 2006-07-11 씨제이 주식회사 시부트라민의 술폰산염
KR20060080817A (ko) 2005-01-06 2006-07-11 씨제이 주식회사 시부트라민의 디카복실산염
JP2008526836A (ja) * 2005-01-06 2008-07-24 シージェー チェイルジェダン コーポレーション シブトラミンの無機酸塩
KR20060093564A (ko) * 2005-02-22 2006-08-25 종근당바이오 주식회사 무수 시부트라민 말산염 및 이의 제조 방법
KR100627687B1 (ko) * 2005-04-20 2006-09-25 주식회사 씨티씨바이오 시부트라민 유리염기 함유 조성물 및 이의 제조방법
JP2010503709A (ja) * 2006-09-15 2010-02-04 レビバ ファーマシューティカルズ，インコーポレーテッド シクロアルキルメチルアミンの合成、使用方法および組成物
BRPI0716002A2 (pt) * 2006-11-22 2013-07-30 Sk Chemicals Co Ltd complexo de inclusço, processo de preparaÇço de um complexo de inclusço e composiÇço de tratamento e prevenÇço de hipocondria e obesidade

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2675573B2 (ja) * 1988-03-31 1997-11-12 科研製薬株式会社 脳機能改善剤
IE61928B1 (en) * 1988-11-29 1994-11-30 Boots Co Plc Treatment of obesity
US5459164A (en) * 1994-02-03 1995-10-17 Boots Pharmaceuticals, Inc. Medical treatment

Also Published As

Publication number Publication date
CA2367021A1 (en) 2000-09-28
WO2000056313A1 (en) 2000-09-28
ZA200107692B (en) 2002-12-18
BG105997A (bg) 2002-06-28
PL350919A1 (en) 2003-02-10
AU3757800A (en) 2000-10-09
CZ291864B6 (cs) 2003-06-18
JP2002539251A (ja) 2002-11-19
SK13352001A3 (sk) 2002-03-05
MXPA01009467A (es) 2004-03-19
KR20020000784A (ko) 2002-01-05
EP1162965A1 (en) 2001-12-19
TR200102695T2 (tr) 2002-01-21
CN1353603A (zh) 2002-06-12
NZ514009A (en) 2001-09-28
NO20014480D0 (no) 2001-09-14
NO20014480L (no) 2001-11-02
BR0009159A (pt) 2001-12-26
HUP0200393A2 (en) 2002-08-28
US6376552B1 (en) 2002-04-23
CZ20013283A3 (cs) 2002-07-17

Similar Documents

Publication Publication Date Title
HUP0202363A2 (en) Medicament useful for treating and/or suppressing weight gain
AU2623201A (en) Controlled delivery of therapeutic agents by insertable medical devices
IL148496A0 (en) Therapeutic quinazoline derivatives
IL145150A0 (en) Pyridopyranoazepine derivatives, preparation and therapeutic use
AU7377200A (en) Combination therapy including camptothecin
AU715620C (en) Therapeutic methods and uses
HUP0200189A3 (en) Transdermal therapeutic system with nicotine
PL350919A1 (en) Method of controlling weight gain associated with therapeutic drugs
PL341619A1 (en) Derivatives of cyclobutane, method of obtaining them and their therapeutic application
HK1047048A1 (en) Therapeutic use of melatonin.
AU4492000A (en) Determination of pacemaker wenckebach and adjustment of upper rate limit
EP1007125A4 (en) CONTROLLING GAS OR MEDICINE ADMINISTRATION TO A PATIENT
HUP0203468A3 (en) Betha-d-5-thioxylose derivatives, preparation method and therapeutic use thereof
AU5646300A (en) Methods of stimulating angiogenesis
IL144762A0 (en) Liposome composition and method for administration of radiosensitizer
HK1048440A1 (zh) 治療體重增加的方法
AU2922700A (en) Cyclobutene-3,4-dione derivatives, preparation method and therapeutic use
IL145239A0 (en) Treatment of certain cancers associated with weight gain
AU1399100A (en) Therapeutic treatment with immunogenic drugs
IL149653A0 (en) 2-arylquinoline derivatives, preparation and therapeutic use thereof
SI1230252T1 (en) Beta-d-5-thioxylose derivatives, preparation method and therapeutic use
AUPQ164599A0 (en) Therapeutic compounds and methods
AUPP973199A0 (en) Therapeutic compounds and methods
GB9921221D0 (en) Method of controlling weeds
AUPQ037399A0 (en) Novel compounds and therapeutic methods